Peer support for people living with hepatitis B virus-A foundation for treatment expansion.
advocacy
hepatitis B infection
patient care
peer support
sustainable development goals
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
26 May 2024
26 May 2024
Historique:
revised:
04
03
2024
received:
30
10
2023
accepted:
05
05
2024
medline:
27
5
2024
pubmed:
27
5
2024
entrez:
27
5
2024
Statut:
aheadofprint
Résumé
Chronic hepatitis B infection (CHB) affects 300 million people worldwide and is being targeted by the United Nations 2030 Sustainable Development Goals (SDGs) and the World Health Organisation (WHO), working towards elimination of hepatitis B virus (HBV) as a public health threat. In this piece, we explore the evidence and potential impact of peer support to enhance and promote interventions for people living with CHB. Peer support workers (PSWs) are those with lived experience of an infection, condition or situation who work to provide support for others, aiming to improve education, prevention, treatment and other clinical interventions and to reduce the physical, psychological and social impacts of disease. Peer support has been shown to be a valuable tool for improving health outcomes for people living with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), but to date has not been widely available for communities affected by HBV. HBV disproportionately affects vulnerable and marginalised populations, who could benefit from PSWs to help them navigate complicated systems and provide advocacy, tackle stigma, improve education and representation, and optimise access to treatment and continuity of care. The scale up of peer support must provide structured and supportive career pathways for PSWs, account for social and cultural needs of different communities, adapt to differing healthcare systems and provide flexibility in approaches to care. Investment in peer support for people living with CHB could increase diagnosis, improve retention in care, and support design and roll out of interventions that can contribute to global elimination goals.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : UCLH Biomedical Research Centre
Organisme : National Institute for Health and Care Research
Organisme : National Health and Medical Research Council
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : University of Oxford
Organisme : Francis Crick Institute
Informations de copyright
© 2024 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Références
Positively UK|support for people living with HIV, from people living with HIV. Positively UK. 2019. Accessed July 17, 2023 https://positivelyuk.org/peer‐support/.
Fleisher JE, Suresh M, Levin ME, et al. Learning to PERSEVERE: a pilot study of peer mentor support and caregiver education in lewy body dementia. Parkinsonism Relat Disord. 2023;113:105492.
Jugnarain DV, Halford R, Smith S, Hickman M, Samartsidis P, Foster GR. Role of peer support in a hepatitis C elimination programme. J Viral Hepat. 2022;29(1):43‐51.
Surey J, Francis M, Gibbons J, et al. Practising critical resilience as an advanced peer support worker in London: a qualitative evaluation of a peer‐led hepatitis C intervention amongst people experiencing homelessness who inject drugs. Int J Drug Policy. 2021;91:103089.
Tan Y, Qin M, Liao B, et al. Effectiveness of peer support on quality of life and anxiety in breast cancer patients: a systematic review and meta‐analysis. Breast Care. 2023;18(1):49‐59.
Shorey S, Chua JYX. Effectiveness of peer support interventions for adults with depressive symptoms: a systematic review and meta‐analysis. J Ment Health. 2023;32(2):465‐479.
Azmiardi A, Murti B, Febrinasari RP, Tamtomo DG. The effect of peer support in diabetes self‐management education on glycemic control in patients with type 2 diabetes: a systematic review and meta‐analysis. Epidemiol Health. 2021;22(43):e2021090.
Grimes HA, Shafiei T, McLachlan HL, Forster DA. Volunteers' experiences of providing telephone‐based breast‐feeding peer support in the RUBY randomised controlled trial. Public Health Nutr. 2020;23(16):3005‐3015.
Otero MÁ, Liu CH, Ampuero J, et al. Peer‐to‐peer sessions in primary care to improve the hepatitis B detection rate in Seville. Spain Ann Hepatol. 2018;17(5):864‐870.
Sievert K, O'Neill P, Koh Y, Lee JH, Dev A, Le S. Engaging new refugee in Australian communities at risk for chronic hepatitis B infection into care: a peer‐educator intervention. Health Soc Care Community. 2018;26:744‐750. doi:10.1111/hsc.12602
Nyamathi A, Salem BE, Zhang S, et al. Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial. Nurs Res. 2015;64(3):177‐189.
Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2024. Licence: CC BYNC‐SA 3.0. https://www.who.int/publications/i/item/9789240090903
GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990‐2019: a systematic analysis for the Global Burden Of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796‐829. doi:10.1016/S2468-1253(22)00124-8
Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub‐Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900‐909.
Wait S, Kell E, Hamid S, et al. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments. Lancet Gastroenterol Hepatol. 2016;1(3):248‐255.
Martyn E, Eisen S, Longley N, et al. The forgotten people: hepatitis B virus (HBV) infection as a priority for the inclusion health agenda. elife. 2023;12. doi:10.7554/eLife.81070
Richmond J, Smith E, Wallace J, Duncan D, Lucke J. Hepatitis B testing and diagnosis experiences of patients and primary care professionals in Australia. Aust Fam Physician. 2017;46(7):513‐519.
Giles‐Vernick T, Hejoaka F, Sanou A, Shimakawa Y, Bamba I, Traoré A. Barriers to linkage to care for hepatitis B virus infection: a qualitative analysis in Burkina Faso, West Africa. Am J Trop Med Hyg. 2016;95(6):1368‐1375.
Mokaya J, McNaughton AL, Burbridge L, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection—a systematic review. Wellcome Open Res. 2018;21(3):29.
Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Chronic hepatitis B stigma in Ghana: a qualitative study with patients and providers. BMJ Open. 2019;9(6):e025503.
Wallace J, Pitts M, Liu C, et al. More than a virus: a qualitative study of the social implications of hepatitis B infection in China. Int J Equity Health. 2017;16(1):137.
Hang Pham TT, Le TX, Nguyen DT, et al. Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. PLoS One. 2019;14(10):e0223733.
Smith‐Palmer J, Cerri K, Sbarigia U, et al. Impact of stigma on people living with chronic hepatitis B. Patient Relat Outcome Meas. 2020;9(11):95‐107.
Muniyandi M, Tyagi K, Singh M, et al. Economic evaluation of implementing a decentralised hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India. Trop Med Int Health. 2021;26(3):374‐384.
Midgard H, Bjørnestad R, Egeland M, et al. Peer support in small towns: a decentralized mobile hepatitis C virus clinic for people who inject drugs. Liver Int. 2022;42(6):1268‐1277.
Chabrol F, Noah Noah D, Tchoumi EP, et al. Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs. BMJ Open. 2019;9(3):e025415.
Mugisha J, Mokaya J, Bukenya D, et al. A study of knowledge, experience, and beliefs about hepatitis B virus (HBV) infection in South Western Uganda. Front Public Health. 2019;25:7.
Dilmitis S, Edwards O, Hull B, et al. Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters. J Int AIDS Soc. 2012;15(4_Suppl 2):17990.
Palermo TM, Long AC, Lewandowski AS, Drotar D, Quittner AL, Walker LS. Evidence‐based assessment of health‐related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol. 2008;33(9):983‐996.
Setia S, Gambhir R, Kapoor V, Jindal G, Garg S, Setia S. Attitudes and awareness regarding hepatitis B and hepatitis C amongst health‐care workers of a tertiary hospital in India. Ann Med Health Sci Res. 2013;3(4):551‐558.
Freeland C, Farrell S, Kumar P, et al. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study. BMC Public Health. 2021;21(1):1004.
Freeland C, Racho R, Kamischke M, et al. Health‐related quality of life for adults living with hepatitis B in the United States: a qualitative assessment. J Patient Rep Outcomes. 2021;5(1):121.
Tu T, Block JM, Wang S, Cohen C, Douglas MW. The lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure. Viruses. 2020;12(5):515. doi:10.3390/v12050515
Ng CJ, Low WY, Wong LP, Sudin MR, Mohamed R. Uncovering the experiences and needs of patients with chronic hepatitis B infection at diagnosis: a qualitative study. Asia Pac J Public Health. 2013;25(1):32‐40.
Matthews PC, Jack K, Wang S, et al. A call for advocacy and patient voice to eliminate hepatitis B virus infection. Lancet Gastroenterol Hepatol. 2022;7(4):282‐285.
Adda D, Wang S. A declaration from people living with hepatitis B: a call for a whole person approach. J Viral Hepat. 2023;30(7):630.
Le T, Vu TTM, Mai HT, et al. Social determinants of stigma and discrimination in Vietnamese patients with chronic hepatitis B. Int J Environ Res Public Health. 2019;16(3):398. doi:10.3390/ijerph16030398
Wallace J, McNally S, Richmond J, Hajarizadeh B, Pitts M. Managing chronic hepatitis B: a qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia. BMC Res Notes. 2011;4(1):45.
Chang ET, Nguyen BH, So SKS. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area. California Asian Pac J Cancer Prev. 2008;9(4):605‐613.
Herink MC, Seaman A, Leichtling G, et al. A randomized controlled trial for a peer‐facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele‐HCV” study. Addict Sci Clin Pract. 2023;18(1):35.
Avramovic G, Reilly M, Cullen W, et al. HEPCARE EUROPE—a case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities. Int J Infect Dis. 2020;101:374‐379.
O'Gorman T, Lambert JS, McHugh T, et al. HepCare plus: enhancing primary care identification and treatment of hepatitis C virus in high‐risk individuals. Pathogens. 2022;11(12):1428. doi:10.3390/pathogens11121428
Grebely J, Gilliver R, McNaughton T, et al. Single‐visit hepatitis C point‐of‐care testing, linkage to nursing care, and peer‐supported treatment among people with recent injecting drug use at a peer‐led needle and syringe program: the TEMPO pilot study. Int J Drug Policy. 2023;114:103982.
Akiyama MJ, Riback LR, Nyakowa M, et al. Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya. Int J Drug Policy. 2023;113:103959.
Stagg HR, Surey J, Francis M, et al. Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention. BMC Med. 2019;17(1):71.
Muzyamba C. “This conflict has turned me into a doctor, nurse and nutritionist at the same time”: how peer support among HIV‐positive IDPs created opportunities for care in conflict‐stricken Kabaré, Congo DR. BMC Res Notes. 2019;12(1):126.
Berg RC, Page S, Øgård‐Repål A. The effectiveness of peer‐support for people living with HIV: a systematic review and meta‐analysis. PLoS One. 2021;16(6):e0252623.
Kanters S, Park JJ, Chan K, et al. Use of peers to improve adherence to antiretroviral therapy: a global network meta‐analysis. J Int AIDS Soc. 2016;19(1):21141.
Hep B Community. Hep B Community. Accessed February 7, 2024 https://www.hepbcommunity.org/
Hep B Voices Aust. RESOURCES. Accessed February 7, 2024 https://www.hepbvoices.au/resources
Nhóm hỗ trợ viêm gan tại Úc. Accessed February 7, 2024 https://www.facebook.com/groups/559761474391494/
Masese LN, Ludwig‐Barron NT, Mbogo L, et al. Occupational roles and risks of community‐embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya. PLoS One. 2022;17(12):e0278210.
Global progress report on HIV, viral hepatitis and sexually transmitted infections. Accountability for the Global Health Sector Strategies 2016–2021: Actions for Impact. World Health Organization; 2021:112.
Bonnington O, Harris M. Tensions in relation: how peer support is experienced and received in a hepatitis C treatment intervention. Int J Drug Policy. 2017;47:221‐229.
World Hepatitis Day. CNWL appoints first hepatitis B peer support worker in the UK. Accessed February 26, 2024 https://www.cnwl.nhs.uk/news/world‐hepatitis‐day‐cnwl‐appoints‐first‐hepatitis‐b‐peer‐support‐worker‐uk
“Putting Community First”; Hep Voice October‐December 2023; https://www.worldhepatitisalliance.org/news/hep‐voice‐october‐december‐2023/
Peer Support for People Living with Hepatitis B. Poster presented at Central North West London NHS Foundation Trust “Safety Conversation”. Accessed November 2023. https://www.cnwl.nhs.uk/application/files/1216/9944/3998/P053_Peer_Support_for_People_Living_with_Hepatitis_B_‐_an_NHS_First_at_CNWL.pdf